Publicaciones (12) Publicaciones en las que ha participado algún/a investigador/a

2003

  1. A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: No differences in cytogenetic responses

    Annals of Hematology, Vol. 82, Núm. 12, pp. 750-758

  2. Acute myeloid leukemia with MLL rearrangements: Clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells

    Leukemia, Vol. 17, Núm. 1, pp. 76-82

  3. Anticoagulación oral

    Anales de medicina interna, Vol. 20, Núm. 7, pp. 377-384

  4. Anticoagulación oral

    Anales de Medicina Interna, Vol. 20, Núm. 7, pp. 377-384

  5. Caso clínico: Síndrome mielodisplásico secundario a tratamiento de leucemia promielocítica aguda

    Hematologia - Citocinas, Inmunoterapia y Terapia Celular, Vol. 6, Núm. 2, pp. 121-128

  6. Exantema generalizado granulomatoso durante un tratamiento con factor estimulante de colonias de granulocitos

    Actas Dermo-Sifiliograficas, Vol. 94, Núm. 6, pp. 402-405

  7. High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: The GEL-TAMO experience

    Annals of Oncology, Vol. 14, Núm. 12, pp. 1768-1775

  8. High-dose therapy in diffuse large cell lymphoma: Results and prognostic factors in 452 patients from the GEL-TAMO Spanish cooperative group

    Annals of Oncology, Vol. 14, Núm. 1, pp. 140-151

  9. Immunophenotypic findings in acute myeloid leukemia with FLT3 internal tandem duplication

    Haematologica, Vol. 88, Núm. 6, pp. 637-645

  10. Incidence and characteristics of myelodysplastic syndromes in Ourense (Spain) between 1994-1998

    Haematologica, Vol. 88, Núm. 10, pp. 1197-1199

  11. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation

    Blood, Vol. 102, Núm. 1, pp. 394-403

  12. Peripheral blood is safer than bone marrow as a source of hematopoietic progenitors in patients with myelodysplastic syndromes who receive an allogeneic transplantation. Results from the Spanish registry

    Bone Marrow Transplantation, Vol. 32, Núm. 10, pp. 987-992